Substance use disorders and HIV/AIDS prevention and treatment intervention: Research and practice considerations

Social Work in Public Health

Volumn 28, Issue 3-4, 2013, Pages 333-348

  Campbell, Aimee N C ^a,b   Tross, Susan ^b,c   Calsyn, Donald A ^d  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c HIV Center for Clinical and Behavioral Studies ^*  (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

evidence based practice; HIV AIDS prevention; HIV AIDS treatment; substance use disorders

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE TRANSMISSION; DISEASE TREATMENT; HUMAN IMMUNODEFICIENCY VIRUS; RESEARCH WORK; SOCIAL WORK; VULNERABILITY;

ADDICTION; ARTICLE; BEHAVIOR THERAPY; COMORBIDITY; EVIDENCE BASED PRACTICE; FEMALE; HEALTH SERVICES RESEARCH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; RISK REDUCTION; SOCIAL WORK; UNITED STATES;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BEHAVIOR THERAPY; COMORBIDITY; EVIDENCE-BASED PRACTICE; FEMALE; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; RISK REDUCTION BEHAVIOR; SOCIAL WORK; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84879121953     PISSN: 19371918     EISSN: 1937190X     Source Type: Journal    
DOI: 10.1080/19371918.2013.774665     Document Type: Article

References (102)

1. Altice, F. L., Maru, D. S.-R., Bruce, R. D., Springer, S. A., & Friedland, G. H. (2007). Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial. Clinical Infectious Diseases, 45, 770-778.
2. Amico, K. R., Harman, J. J., & Johnson, B. J. (2006). Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004. Journal of Acquired Immune Deficiency Syndromes, 41, 285-297.
3. Ball, J. C., & Ross, A. (1991). The effectiveness of methadone maintenance treatment. New York, NY: Springer Verlag.
4. Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367, 399-410.
5. Bell, C., Metsch, L. R., Vogenthaler, N., Cardenas, G., Rodriguez, A., Locascio, V., del Rio, C. (2010). Never in care: Characteristics of HIV-infected crack cocaine users in two U.S. cities who have never been to outpatient HIV care. Journal of Acquired Immune Deficiency Syndromes, 54(4), 376-380.
6. Berg, K. M., Litwin, A., Li, X., Heo, M., & Arnsten, J. H. (2011). Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial. Drug and Alcohol Dependence, 113, 192-199.
7. Berns, S. B., & Calsyn, D. A. (2005, June). Improving alcoholism counselors' knowledge about the sexual behavior of their clients. Poster presented at the Annual Scientific Meetings of the College on Problems of Drug Dependence, Orlando FL.
8. Booth, R. E., Campbell, B. K., Mikulich-Gilbertson, S. K., Tillotson, C. J., Choi, D., Robinson, J., McCarty, D. (2011). Reducing HIV-related risk behaviors among IDUs in residential detoxification. AIDS and Behavior, 15(1), 30-44.
9. Booth, R. E., Kwaitkowski, C. F., & Stephens, R. C. (1998). Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users. Journal of Psychoactive Drugs, 30(3), 269-278.
10. Branson, B. M., Handsfield, H. H., Lampe, M. A., Janssen, R. S., Taylor, A. W., Lyss, S. B., Centers for Disease Control and Prevention (CDC). (2006). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morbidity and Mortality Weekly Report, 55(RR-14), 1-17.
11. Brown, L. S., Jr., Kritz, S. A., Goldsmith, R. J., Bini, E. J., Rotrosen, J., Baker, S., McAuliffe, P. (2006). Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The national drug abuse treatment Clinical Trials Network. Journal of Substance Abuse Treatment, 30(4), 315-321.
12. Carrico, A. W. (2011). Substance use and HIV disease progression in the HAART era: Implications for the primary prevention of HIV. Life Science, 88(21/22), 940-947.
13. Calsyn, D. A., Burlew, A. K., Hatch-Maillette, M. A., Beadnell, B., Wright, L., & Wilson, J. (2013). An HIV prevention intervention for ethnically diverse men in substance abuse treatment: Pilot study findings. American Journal of Public Health. doi:10.2105/AJPH.2012.300970
14. Calsyn, D. A., Crits-Christoph, P., Hatch-Maillette, M. A., Doyle, S. R., Song, Y. S., Coyer, S., & Pelta, S. (2010). Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment. Addiction, 105(1), 100-108.
15. Calsyn, D. A., Hatch-Maillette, M., Tross, S., Doyle, S. R., Crits-Christoph, P., Song, Y. S., Berns, S. B. (2009). Motivational and skills training HIV/STI sexual risk reduction groups for men. Journal of Substance Abuse Treatment, 37(2), 138-150.
16. Centers for Disease Control and Prevention. (2008). HIV prevalence estimates-United States, 2006. Morbidity and Mortality Weekly Report, 57(39), 1073-1076.
17. Centers for Disease Control and Prevention. (2009). HIV Surveillance Report (Vol. 21). Retrieved from http://www.cdc. gov/hiv/topics/surveillance/ resources/reports/
18. Centers for Disease Control and Prevention. (2011a). CDC trial and another major study find PrEP can reduce risk of HIV infection among heterosexuals [Press release]. Retrieved fromhttp://www.cdc.gov/nchhstp/ newsroom/PrEPHeterosexuals. html.
19. Centers for Disease Control and Prevention. (2011b). High-impact HIV prevention: CDC's approach to reducing HIV infections in the United States. Retrieved from http://www.cdc.gov/hiv/strategy/hihp/index.htm
20. Centers for Disease Control and Prevention. (2011c). Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. Morbidity and Mortality Weekly Report, 60(3), 65-68.
21. Centers for Disease Control and Prevention. (2012a). HIV among gay and bisexual men. Retrieved from http://www.cdc. gov/hib/topics/msm/index.htm
22. Centers for Disease Control and Prevention. (2012b). HIV Surveillance Report (2010, Vol. 22). Retrieved from http://www.cdc.gov/hiv/topics/ surveillance/resources/reports/
23. Charania, M. R., Crepaz, N., Guenther-Gray, C., Henny, K., Liau, A., Willis, L. A., & Lyles, C. M. (2011). Efficacy of structural-level condom distribution interventions: A meta-analysis of U.S. and international studies, 1998-2007. AIDS and Behavior, 15(7), 1283-1297.
24. Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., : : :HPTN 0052 Study Team. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365, 493-505.
25. Colfax, G., & Shoptaw, S. (2005). The methamphetamine epidemic: Implications for HIV prevention and treatment. Current HIV/AIDS Reports, 2(4), 194-199.
26. Copenhaver, M., Johnson, B., Lee, I., Harman, J., Carey, M., & the SHARP Research Team. (2006). Behavioral HIV risk reduction among people who inject drugs: Meta-analytic evidence of efficacy. Journal of Substance Abuse Treatment, 31, 163-171.
27. Craw, J. A., Gardner, L. I., Marks, G., Rapp, R. C., Bosshart, J., Duffus, W. A., Schmitt, K. (2008). Brief strengthsbased case management promotes entry into HIV medical care: Results of the Antiretroviral Treatment Access Study-II. Journal of Acquired Immune Deficiency Syndromes, 47(5), 597-606.
28. D'Aunno, T. D., Vaughn, T. E., & McElroy, P. (1999). An institutional analysis of HIV prevention efforts by the national outpatient drug abuse treatment units. Journal of Health and Social Behavior, 40(2), 175-192.
29. Des Jarlais, D., Arasteh, K., Perlis, T., Hagan, H., Abdul-Quader, A., Heckathorn, D., Friedman, S. R. (2007). Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS, 21, 231-235.
30. Des Jarlais, D. C., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., Friedman, S. R. (2001). HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic. American Journal of Public Health, 90(3), 352-359.
31. Des Jarlais, D. C., & Semaan, S. (2008). HIV prevention for injecting drug users: The first 25 years and counting. Psychosomatic Medicine, 70(5), 606-611.
32. Durlak, J. A., & DuPre, E. P. (2008). Implementation matters: A review of research on the influence of implementation on program outcomes and the factors affecting implementation. American Journal of Community Psychology, 41(3/4), 327-350.
33. El-Bassel, N., Schilling, R. F., Irwin, K. L., Faruque, S., Gilbert, L., Von Bargen, J., Edlin, B. R. (1997). Sex trading and psychological distress among women recruited from the streets of Harlem. American Journal of Public Health, 87(1), 66-70.
34. Exner, T., Seal, D., & Ehrhardt, A. (1997). A review of HIV interventions for at-risk women. AIDS and Behavior, 2, 93-124.
35. Exner, T. M., Tesoriero, J. M., Battles, H. B., Hoffman, S., Mantell, J. E., Correale, J., Klein, S. J. (2012). A randomized controlled trial to evaluate a structural intervention to promote the female condom in New York State. AIDS and Behavior, 16, 1121-1132.
36. Fielden, S. J., Rusch, M. L., Levy, A. R., Yip, B., Wood, E., Harrigan, R. P., Hogg, R. S. (2008). Predicting hospitalization among HIV-infected antiretroviral naive patients starting HAART: Determining clinical markers and exploring social pathways. AIDS Care, 20(3), 297-303.
37. Fisher, J. D., & Fisher, W. A. (2000). Theoretical approaches to individual-level change in HIV risk behavior (Paper 4). In J. L. Peterson & R. J. DiClemente (Eds.), Handbook of HIV prevention (pp. 3-55). New York, NY: Kluwer/Plenum. Retrieved from http://digitalcommons.uconn.edu/chip-docs/4
38. Fixsen, D. L, Naoom, S. F., Blase, K. A., Friedman, R. M., & Wallace, F. (2005). Implementation research: A synthesis of the literature (FMHI Publication #231). Tampa, FL: University of South Florida, Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network.
39. Gandelman, A. A., DeSantis, L. M., & Rietmeijer, C. A. (2006). Assessing community needs and agency capacity- An integral part of implementing effective evidence-based interventions. AIDS Education and Prevention, 18(4, SA), 32-43.
40. Gardner, L. I., Metsch, L. R., Anderson-Mahoney, P., Loughlin, A. M., del Rio, C., Strathdee, S., Antiretroviral Treatment and Access Study Group. (2005). Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS, 19, 423-431.
41. Grant, R. M., Lama, J. R., Anderson, P. L., McMahon, V., Liu, A. Y., Vargas, L., iPrEx Study Team. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363, 2587-2599.
42. Hall, H. I., Song, R., Rhodes, P., Prejean, J., An, Q., Lee, L. M., HIV Incidence Surveillance Group. (2008). Estimation of HIV incidence in the United States. Journal of the American Medical Association, 300(5), 520-529.
43. Haynes, L. F., Calsyn, D. A., & Tross, S. (2008). Addressing sexual issues in addictions treatment. Counselor, 9(4), 28-36.
44. Hendershot, C. S., Stoner, S. A., Pantalone, D. W., & Simoni, J. M. (2009). Alcohol use and antiretroviral adherence: Review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 52(2), 180-202.
45. Holmes, B. W., Haynes, L. F., Korte, J. E., & Brady, K. T. (2011, June). Adoption of a rapid HIV testing and counseling program facilitates state-wide implementation. Poster presented at the College on Problems of Drug Dependence, Hollywood, FL.
46. Hull, M.W., & Montaner, J. (2011). Antiretroviral therapy: A key component of a comprehensive HIV prevention strategy. Current HIV/AIDS Report, 8(2), 85-93.
47. Ingersoll, K. S., Farrell-Carnahana, L., Cohen-Filipic, J., Heckmand, C. J., Ceperich, S. D., Hettema, J., & Marzani-Nissen, G. (2011). A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV + crack cocaine users. Drug and Alcohol Dependence, 116, 177-187.
48. Jemmott, L. S., Jemmott, J. B., III, & O'Leary, A. (2007). Effects on sexual risk behavior and STD rate of brief HIV/STD prevention interventions for African American women in primary care settings. American Journal of Public Health, 97, 1034-1040.
49. Kamb, M. L., Fishbein, M., Douglas, J. M., Rhodes, F., Rogers, J., Bolan, G., Peterman, T. A. (1998). Efficacy of risk-reduction counseling to prevention human immunodeficiency virus and sexually transmitted diseases, Project RESPECT Study Group. Journal of the American Medical Association, 280(13), 1161-1167.
50. Klein, K. J., & Knight, A. P. (2005). Innovation implementation: Overcoming the challenge. Current Directions in Psychological Science, 14(5), 243-246.
51. Koenig, L. J., Pals, S. L., Bush, T., Pratt, M. P., Stratford, D., & Ellerbrock, T. V. (2008). Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychology, 27(2), 159-169.
52. Lamb, S., Greenlick, M. R., & McCarty, D. (1998). Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment. Washington, DC: National Academy Press.
53. Langford, S. E., Ananworanich, J., & Cooper, D. A. (2007). Predictors of disease progression in HIV infection: A review. AIDS Research & Therapy, 4(11), 1-14. doi:10.1186/1742-6405-4-11.
54. Latka, M. H., Hagan, H., Kapadia, F., Golub, E. T., Bonner, S., Campbell, J. V., Strathdee, S. A. (2008). A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. American Journal of Public Health, 98, 853-861.
55. Latkin, C. A., Curry, A. D., Hua, W., & Davey, M. A. (2007). Direct and indirect associations of neighborhood disorder with drug use and high-risk sexual partners. American Journal of Preventive Medicine, 32, 234-241.
56. Latkin, C. A., Sherman, S., & Knowlton, A. (2003). HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology, 22(4), 332-339.
57. Lin Miller, R., & Greene, G. J. (2005). Transferring HIV prevention technology to community-based organizations: How can HIV prevention scientists play an effective role in practice? In E. J. Trickett & W. Pequegnat (Eds.), Community interventions and AIDS (pp. 196-221). New York, NY: Oxford University Press.
58. Logan, T. K., Cole, J., & Leukefeld, C. (2002). Women, sex, and HIV: Social and contextual factors, meta-analysis of published interventions, and implications for practice and research. Psychological Bulletin, 128(6), 851-885.
59. Lucas, G. M., Mullen, B. A., Weidle, P. J., Hader, S., McCaul, M. E., & Moore, R. D. (2006). Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes among concurrent comparison groups. Clinical Infectious Diseases, 42, 1628-1635.
60. Lucas, G. M., Mullen, B. A., Weidle, P. J., Hader, S., McCaul, M. E., & Moore, R. D. (2010). Directly administered antiretroviral therapy in methadone clinics is associated with improvedHIV treatment outcomes comparedwith outcomes among concurrent comparison group. Clinical Infectious Diseases, 42, 1628-1635.
61. Malta, M., Magnanini, M. M. F., Strathdee, S. A., & Bastos, F. I. (2010). Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. AIDS & Behavior, 14, 731-747.
62. Meader, N., Li, R., Des Jarlais, D. C., & Pilling S. (2010). Psychosocial interventions for reducing injection and sexual risk behavior for preventing HIV in drug users. Cochrane Database Systematic Review, 1, CD007192.
63. Mellins, C. A., Havens, J. F., McDonnell, C., Lichtenstein, C., Uldall, K., Chesney, M., Bell, J. (2009). Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care, 21(2), 168-177.
64. Metcalf, C., Malotte, K., Douglas, J. M., Paul, S. M., Dillon, B., Cross, H., RESPECT-2 Study Group. (2005). Efficacy of a booster counseling session 6 months after HIV testing and counseling: A randomized, controlled trial (RESPECT-2). Sexually Transmitted Diseases, 32(2), 123-129.
65. Metsch, L. R., Bell, C., Pereya, M., Cardenas, G., Sullivan, T., Rodriguez, A., del Rio, S. (2009). Hospitalized HIVinfected patients in the era of highly active antiretroviral therapy. American Journal of Public Health, 99(6), 1045-1049.
66. Metsch, L. R., Feaster, D. J., Gooden, L. K., Matheson, T., Mandler, R. N., Haynes, L. F., Colfax, G. N. (2012). Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: Results of a randomized trial. American Journal of Public Health, 102(6), 1160-1167.
67. Metzger, D. S., Woody, G. E., & O'Brien, C. P. (2010). Drug treatment as HIV prevention: A research update. Journal of Acquired Immune Deficiency Syndromes, 55, S32-S36.
68. Milloy, M. S., Marshall, B. D. L., Kerr, T., Buxton, J., Rhodes, T., Montaner, J., Wood, E. (2012). Social and structural factors associated with HIV disease progression among illicit drug users: A systematic review. AIDS, 26, 1049-1063.
69. Milam, J., Richardson, J. L., McCutchan, A., Stoyanoff, S., Weiss, J., Kemper, C., Bolan, R. (2005). Effect of a brief antiretroviral adherence intervention delivered by HIV care providers. Journal of Acquired Immune Deficiency Syndromes, 40(3), 356-363.
70. Mitchell, C. G., & Oltean, A. (2007). Integrating HIV prevention into substance user treatment: Current practices and challenges. Substance Use & Misuse, 42(14), 2173-2182.
71. National Institutes of Health. (2006). Dissemination and implementation research in health (R01). Retrieved from http://grants.nih.gov/grants/guide/pa- files/PAR-07-086.html
72. National Institutes of Health Office of AIDS Research. (2011). FY2011 trans-NIH plan and presidential by-pass budget. Retrieved from www.oar.nih.gov/budget/pdf/2010-0129-CJ2011.pdf
73. O'Donnell, C. R., O'Donnell, L., San Doval, A., Duran, R., & Labes, K. (1998). Reductions in STD infections subsequent to an STD clinic visit: Using video-based patient education to supplement provider interactions. Sexually Transmitted Diseases, 25(3), 161-168.
74. Owczarzak, J., & Dickson-Gomez, J. (2011). Providers' perception of and receptivity toward evidence-based HIV prevention interventions. AIDS Education and Prevention, 23(2), 105-117.
75. Parsons, J. T., Golub, S. A., Rosof, E., & Holder, C. (2007).Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: A randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes, 46(4), 443-450.
76. Pollack, H. A., & D'Aunno, T. (2010). HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005. Journal of Substance Abuse Treatment, 38(4), 307-316.
77. Prendergast, M., Urada, D., & Podus, D. (2001). Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. Journal of Consulting and Clinical Psychology, 69, 389-405.
78. Raj, A., Saitz, R., Cheng, D. M., Winter, M., & Samet, J. H. (2007). Associations between alcohol, heroin and cocaine use and high risk sexual behaviors among detoxification patients. American Journal of Drug and Alcohol Abuse, 33, 169-178.
79. Remien, R. H., Stirratt, M. J., Dolezal, C., Dognin, J. S., Wagner, G. J., Carballo-Dieguez, A., Jung, T. M. (2005). Couple-focused support to improve HIV medication adherence: A randomized controlled trial. AIDS, 19, 807-814.
80. Robles, R. M., Reyes, J. C., Colon, H. M., Sahai, H., Marrero, C. A., Matos, T. D., Shepard, E. W. (2004). Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: A randomized controlled study. Journal of Substance Abuse Treatment, 27, 145-152.
81. Rogers, E. M. (2003). Diffusion of innovations (5th ed.). New York, NY: Free Press.
82. Rotheram-Borus, M., Swendeman, D., Comulada, S., Weiss, R. E., Lee, M., & Lightfoot, M. (2004). Prevention for Substance-using HIV positive young people: Telephone and in-person delivery. Journal of Acquired Immune Deficiency Syndromes, 37(2), S68-S77.
83. Rotrosen, J., Leshner, A. I., Tai, B., Greenlick, M. R., Pencer, E., Trachtenberg, R., & Woody, G. (2002). The National Drug Abuse Treatment Clinical Trials Network-Challenges and opportunities. NIDA ResearchMonograph, 182, 12-17.
84. Schoenbaum, E. E., Lo, Y., & Floris-Moore, M. (2002). Predictors of hospitalization for HIV-positive women and men drug users: 1996-2000. Public Health Reports, 117(S1), S60-S66.
85. Semaan, S., Des Jarlais, D., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., Needle, R. (2002). A metaanalysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. JAIDS, 30(S1), S73-S93.
86. Shoptaw, S., Tross, S., Stephens, M., and the NIDA CTN HIV/AIDS Workgroup. (2002). A snapshot of HIV/AIDS-related services in the clinical treatment providers for NIDA's Clinical Trials Network. Drug and Alcohol Dependence, 66(S1), S163.
87. Sorensen, J., & Copeland, A. (2000). Drug abuse treatment as an HIV prevention strategy: A review. Drug and Alcohol Dependence, 59, 17-31.
88. Sorensen, J. L., Haug, N. A., Deluchhi, K. L., Gruber,V., Kletter, E., Batki, S. L., Hall, S. (2006).Voucher reinforcement improves medication adherence in HIV-positive methadone patients: A randomized trial. Drug and Alcohol Dependence, 88(1), 54-63.
89. Sterk, C. E., Theall, K. P., & Elifson, K. W. (2003). Effectiveness of a risk reduction intervention among African American women who use crack cocaine. AIDS Education and Prevention, 15, 15-32.
90. Strathdee, S. A., & Vlahov, D. (2001). The effectiveness of needle exchange programmes: A review of the science and policy. AIDS Science, 1(16), 1-33.
91. Strauss, S. M., Des Jarlais, D. C., Astone, J., & Vassilev, Z. P. (2003). On-site HIV testing in residential drug treatment units: Results of a nationwide survey. Public Health Reports, 118(1), 37-43.
92. Terzian, A. S., Bodah, S. D., Wiewel, E. W., Sepkowitz, K., Bernard, M., Braunstein, S. L., & Shepard, C. W. (2012). Novel use of surveillance data to detect HIV-infected persons with sustained high viral load and durable virologic suppression in New York City. PLoS One, 7(1), e29679.
93. Tross, S., Campbell, A. N. C., Calsyn, D. A., Metsch, L. R., Sorensen, J. L., Shoptaw, S., Clinial Trials Network HIV Special Interest Group. (2011). NIDA's Clinical Trials Network: An opportunity for HIV research in community substance abuse treatment programs. American Journal of Drug and Alcohol Abuse, 37(5), 283-293.
94. Tross, S., Campbell, A. N. C., Cohen, L. R., Calsyn, D., Pavlicova,M., Miele, G. M., Nunes, E. V. (2008). Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: Results of a NIDA Clinical Trials Network trial. Journal of Acquired Immune Deficiency Syndromes, 48(5), 581-589.
95. U.S. Census Bureau. (2009). Population estimates. Retrieved from http://www.census.gov/popest/estbygeo.html
96. U.S. Department of Health and Human Services. (2011). Guide for HIV/AIDS clinical care. Rockville, MD: USDHHS, Health Resources and Services Administration, HIV/AIDS Bureau.
97. Volkow, N. D., Baler, R. D., & Normand, J. L. (2011). The unrealized potential of addiction science in curbing the HIV epidemic. Current HIV Research, 9(6), 393-395.
98. Warner, L., Klausner, J. D., Rietmeijer, C. A., Malotte, C. K., O'Donnell, L., Margolis, A. D., Safe in the City Study Group. (2008). Effects of a brief video intervention on incident infection among patients attending sexually transmitted disease clinics. PLoS Med, 5(6), e135. doi:10.1371/journal. pmed.0050135
99. White House Office of National AIDS Policy. (2010). National HIV/AIDS strategy for the United States. Retrieved from http://www.whitehouse.gov/sites/ default/files/uploads/NHAS.pdf.
100. Wilton, L., Herbst, J. H., Coury-Doniger, P., Painter, T. M., English, G., Alvarez, M. E., Carey, J. W. (2009). Efficacy of an HIV/STI prevention intervention for black men who have sex with men: Findings from the Many Men, Many Voices (3MV) Project. AIDS and Behavior, 13, 532-544.
101. Wood, E., Kerr, T., Tyndall, M. W., & Montaner, J. S. (2008). A review of barriers and facilitators of HIV treatment among injection drug users. AIDS, 11(22), 1247-1256.
102. World Health Organization. (2004). Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Retrieved from www.who.int/hiv/pub/prev-care/effectivenesssterileneedle.pdf.